Fig. 2From: Effectiveness and safety of tafluprost in primary open-angle glaucoma and ocular hypertension: a post-marketing phase IV study in ChinaResponse rate of intraocular pressure (IOP) reduction ≥ 10%, ≥ 20%, and ≥ 30% in Group A at the last visit. A All; B Baseline IOP ≤ 21 mmHg; C Baseline IOP ≥ 24 mmHg; D response rate of IOP ≤ 16 mmHg, ≤ 18 mmHg, ≤ 20 mmHg in Group A at the last visitBack to article page